Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-045414
Filing Date
2023-08-11
Accepted
2023-08-11 16:05:37
Documents
1
Period of Report
2023-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 30942
  Complete submission text file 0001209191-23-045414.txt   32465
Mailing Address 132 PURDURE AVENUE KENGSINGTON CA 94708
Business Address
BJERKHOLT ERIC (Reporting) CIK: 0001197350 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37345 | Film No.: 231164011

Mailing Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109
Business Address 400 FAIRVIEW AVENUE NORTH, SUITE 900 SEATTLE WA 98109 206-485-7051
CHINOOK THERAPEUTICS, INC. (Issuer) CIK: 0001435049 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations